Active Ingredient Selexipag

Active Ingredient Details

What is the usage for Selexipag?

Selexipag is used to treat high blood pressure in the lungs (pulmonary arterial hypertension-PAH). It is used to help slow down worsening of PAH and to decrease the chance of needing treatment in a hospital. Selexipag works by making it easier for blood to flow through the arteries in your lungs. This effect helps increase your ability to exercise.

How many products in the NDC database contain Selexipag?

The NDC database has 34 products with the active ingredient Selexipag. The following table lists all the products that have this active ingredient.

NDC Products with Selexipag

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
14501-0116Proprietary Name: SelexipagPowderMsn Laboratories Private LimitedACTIVE
42973-307Proprietary Name: Selexipag-mannitol PremixPowderApicore Pharmaceuticals Private LimitedACTIVE
46014-0602Proprietary Name: SelexipagCapsuleExcella Gmbh & Co. KgACTIVE
46014-0608Proprietary Name: SelexipagCapsuleExcella Gmbh & Co. KgACTIVE
46014-0621Proprietary Name: SelexipagCapsuleExcella Gmbh & Co. KgACTIVE
46014-6040Proprietary Name: UptraviCapsuleExcella Gmbh & Co. KgACTIVE
46014-6060Proprietary Name: UptraviCapsuleExcella Gmbh & Co. KgACTIVE
46014-6100Proprietary Name: UptraviCapsuleExcella Gmbh & Co. KgACTIVE
46014-6120Proprietary Name: UptraviCapsuleExcella Gmbh & Co. KgACTIVE
46014-6140Proprietary Name: UptraviCapsuleExcella Gmbh & Co. KgACTIVE
46014-6160Proprietary Name: UptraviCapsuleExcella Gmbh & Co. KgACTIVE
47848-060Proprietary Name: SelexipagPowderTeva Czech Industries S.r.oACTIVE
58159-113Proprietary Name: SelexipagPowderNuray Chemicals Private LimitedACTIVE
66215-602Proprietary Name: Uptravi SelexipagTablet, CoatedOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-604Proprietary Name: Uptravi SelexipagTablet, CoatedOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-606Proprietary Name: Uptravi SelexipagTablet, CoatedOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-608Proprietary Name: Uptravi SelexipagTablet, CoatedOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-610Proprietary Name: Uptravi SelexipagTablet, CoatedOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-612Proprietary Name: Uptravi SelexipagTablet, CoatedOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-614Proprietary Name: Uptravi SelexipagTablet, CoatedOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-616Proprietary Name: Uptravi SelexipagTablet, CoatedOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-718Proprietary Name: Uptravi SelexipagInjection, Powder, For SolutionIntravenousActelion Pharmaceuticals Us, Inc.ACTIVE
69037-0036Proprietary Name: Selexipag AmorphousPowderHonour Lab LimitedACTIVE
70600-007Proprietary Name: SelexipagPowderMaithri Drugs Private LimitedACTIVE
70600-011Proprietary Name: Selexipag (form-i)PowderMaithri Drugs Private LimitedACTIVE
70600-029Proprietary Name: SelexipagPowderMaithri Drugs Private LimitedACTIVE
70710-1551Proprietary Name: Selexipag SelexipagTablet, Film CoatedOralZydus Pharmaceuticals (usa) Inc.ACTIVE
70710-1552Proprietary Name: Selexipag SelexipagTablet, Film CoatedOralZydus Pharmaceuticals (usa) Inc.ACTIVE
70710-1553Proprietary Name: Selexipag SelexipagTablet, Film CoatedOralZydus Pharmaceuticals (usa) Inc.ACTIVE
70710-1554Proprietary Name: Selexipag SelexipagTablet, Film CoatedOralZydus Pharmaceuticals (usa) Inc.ACTIVE
70710-1555Proprietary Name: Selexipag SelexipagTablet, Film CoatedOralZydus Pharmaceuticals (usa) Inc.ACTIVE
70710-1556Proprietary Name: Selexipag SelexipagTablet, Film CoatedOralZydus Pharmaceuticals (usa) Inc.ACTIVE
70710-1557Proprietary Name: Selexipag SelexipagTablet, Film CoatedOralZydus Pharmaceuticals (usa) Inc.ACTIVE
70710-1558Proprietary Name: Selexipag SelexipagTablet, Film CoatedOralZydus Pharmaceuticals (usa) Inc.ACTIVE
<